Results 111 to 120 of about 37,927 (295)

Serum thyroid hormone antibodies are frequent in patients with polyglandular autoimmune syndrome type 3, particularly in those who require thyroxine treatment [PDF]

open access: yes, 2017
Polyglandular autoimmune syndrome (PAS) type 3 consists of autoimmune thyroid disease (AITD) coexisting with ≥1 non-thyroidal autoimmune disease (NTAID) other than Addison’s disease and hypoparathyroidism. We evaluated the prevalence and repertoire of
Benvenga, Salvatore   +8 more
core   +1 more source

Impact of the 2015 American Thyroid Association Guidelines on Treatment of Low‐Risk Thyroid Cancer

open access: yesLaryngoscope Investigative Otolaryngology, Volume 10, Issue 3, June 2025.
ABSTRACT Objectives The 2015 American Thyroid Association (ATA) guidelines recommended lobectomy for management of low‐risk differentiated thyroid carcinomas (DTC), aiming to mitigate overtreatment. The primary objective of this study was to assess the impact of the 2015 ATA guidelines on the rates of lobectomy versus total thyroidectomy for the ...
Akash S. Halagur   +2 more
wiley   +1 more source

Epidemiology and Diagnosis of Hypoparathyroidism.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2016
CONTEXT Hypoparathyroidism is a disorder characterized by hypocalcemia due to insufficient secretion of PTH. Pseudohypoparathyroidism is a less common disorder due to target organ resistance to PTH.
B. Clarke   +9 more
semanticscholar   +1 more source

Treatment of severe idiopathic hypoparathyroidism: a case report

open access: yesОстеопороз и остеопатии, 2018
Hypoparathyroidism is a rare disorder characterized by parathyroid hormone (PTH) insufficiency, the development of hypocalcemia and alteration of bone tissue remodeling.
Diliara Sh. Umiarova   +3 more
doaj   +1 more source

Finnish nationwide controlled register study found increased inpatient infections in children with 22q11.2 deletion syndrome

open access: yesActa Paediatrica, Volume 114, Issue 6, Page 1298-1304, June 2025.
Abstract Aim Studies on treating infections in children with 22q11.2 deletion syndrome (22q11.2DS) have been limited. We characterised inpatient infections and outpatient antibiotic treatment. Methods Children born during 2005–2018 were eligible for this national Finnish retrospective register‐based study.
Sakari Wahrmann   +3 more
wiley   +1 more source

Management of Hypoparathyroidism: Summary Statement and Guidelines.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2016
OBJECTIVE Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent or deficient PTH. This report presents a summary of current information about epidemiology, presentation, diagnosis, clinical features, and management and proposes ...
M. Brandi   +7 more
semanticscholar   +1 more source

Persistent hypocalcaemia in a Chinese girl due to a novel de-novo activating mutation of the calciumsensing receptor gene [PDF]

open access: yes, 2011
A significant proportion of patients formerly diagnosed with idiopathic hypoparathyroidism actually have activating mutation of the calcium-sensing receptor (CaSR) gene.
Lam, CW, Tong, CT, Tong, SF, Wong, WC
core  

Hypoparathyroidism: etiology, clinical manifestation, current diagnostics and treatment

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
Parathyroid hormone (PTH) is the main regulator of calcium and phosphorus metabolism. PTH deficiency or tissue resistance to its effects results in hypoparathyroidism characterized by low serum calcium and elevated serum phosphate levels. The most common
A. K. Eremkina, E. V. Kovaleva
doaj   +1 more source

Presentation of Hypoparathyroidism: Etiologies and Clinical Features.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2016
CONTEXT Understanding the etiology, diagnosis, and symptoms of hypoparathyroidism may help to improve quality of life and long-term disease outcomes.
D. Shoback   +11 more
semanticscholar   +1 more source

Activating Antibodies to Calcium-Sensing Receptor In Immunotherapy-Induced Hypoparathyroidism.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2020
CONTEXT Immune checkpoint inhibitors (ICIs), as anti-programmed cell death protein-1 (PD-1), anti-programmed cell death protein-ligand 1 (PD-L1), and anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) monoclonal antibodies, are approved for the treatment of ...
I. Lupi   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy